Search Result "filgotinib"
Clinical Confirmation that the Selective JAK1 Inhibitor Filgotinib (GLPG0634) has a Low Liability for Drug-drug Interactions
Journal: Drug Metabolism Letters
Volume: 10 Issue: 1 Year: 2016 Page: 38-48
Author(s): Florence Namour,Julie Desrivot,Annegret Van der Aa,Pille Harrison,Gerben van`t Klooster,Chantal Tasset
Current Remedial Strategies for the Treatment of Rheumatoid Arthritisthrough the Oral Route with Janus Kinase Inhibitors
Journal: Drug Delivery Letters
Volume: 13 Issue: 1 Year: 2023 Page: 13-23
Author(s):
JAK Inhibition as a Therapeutic Strategy for Inflammatory Bowel Disease
Journal: Current Drug Metabolism
Volume: 21 Issue: 4 Year: 2020 Page: 247-255
Author(s): Fabio Salvatore Macaluso,Iago RodrÃguez-Lago
Novel Therapeutic Approaches in Rheumatoid Arthritis: Role of Janus Kinases Inhibitors
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 16 Year: 2019 Page: 2823-2843
Author(s): Felice Rivellese,Antonio Lobasso,Letizia Barbieri,Bianca Liccardo,Amato de Paulis,Francesca Wanda Rossi
Rheumatoid Arthritis and JAK-STAT Inhibitors: Prospects of TopicalDelivery
Journal: Current Drug Therapy
Volume: 17 Issue: 2 Year: 2022 Page: 86-95
Author(s):
Targeting Janus Kinase (JAK) for Fighting Diseases: The Research ofJAK Inhibitor Drugs
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 29 Year: 2022 Page: 5010-5040
Author(s):
Meet Our Editorial Board Member
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 20 Issue: 3 Year: 2017 Page: 183-183
Author(s): Thierry Christophe
A Systematic Review of the Novel Targeted Immunobiological Medications inRheumatoid Arthritis: Efficacy, Safety, and Innovation
Journal: New Emirates Medical Journal
Volume: 5 Issue: 1 Year: 2024 Page: 1-10
Author(s):
JAK Inhibition: The Most Promising Agents in the IBD Pipeline?
Journal: Current Pharmaceutical Design
Volume: 25 Issue: 1 Year: 2019 Page: 32-40
Author(s): Agnès Fernández-Clotet,Jesús Castro-Poceiro,Julián Panés
Biologic Therapy in Crohnâs DiseaseâWhat We Have Learnt So Far
Journal: Current Drug Targets
Volume: 21 Issue: 8 Year: 2020 Page: 792-806
Author(s): Kinga Majchrzak,Jakub Fichna